Like the trend observed for hs‐CRP, the serum concentration of MPO was significantly decreased (p < 0.0001) when dogs transitioned from WD to CD2 but was different from the MPO serum concentration of dogs in CD1 (Figure 5). This evidence concerns the gene MPO and Wilson disease.